Link to full Substack Article

There’s been plenty of debate lately about the discovery of benzene in benzoyl peroxide (BPO) acne products. Some people call it fear mongering. I disagree. What we’re seeing is the quality control system functioning as it should—independent testing, regulatory oversight, and corrective actions when warranted.

As someone with experience in pharmaceutical development, stability testing, and regulatory compliance, this situation feels familiar. It’s a textbook example of how systems are designed to protect human health, not just react to a crisis.